Literature DB >> 25691333

Postoperative risk of venous thromboembolism in rheumatic disease patients.

Lauren E Wong1, Anne R Bass.   

Abstract

Both traditional and disease-related risk factors for venous thromboembolism (VTE) must be considered when assessing rheumatic disease patients preoperatively. While many studies suggest that patients with rheumatic diseases are at higher risk of VTE overall, studies in rheumatoid arthritis patients do not demonstrate an increased risk of postoperative VTE. Here, we review the literature on VTE risk in patients with rheumatoid arthritis, systemic lupus erythematosus, Behcet's disease, and vasculitis. The data suggest that disease activity is a driver of VTE risk. While rheumatoid arthritis patients undergoing elective arthroplasty are not at elevated VTE risk, patients with systemic lupus erythematosus and antiphospholipid antibody syndrome undergoing surgery have an elevated risk of postoperative VTE.

Entities:  

Mesh:

Year:  2015        PMID: 25691333     DOI: 10.1007/s11926-014-0488-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  61 in total

1.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Authors:  J Antonio Aviña-Zubieta; Vidula M Bhole; Neda Amiri; Eric C Sayre; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

2.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

3.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

4.  Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.

Authors:  Chi Chiu Mok; Sandy Shuk Kuen Tang; Chi Hung To; Michelle Petri
Journal:  Arthritis Rheum       Date:  2005-09

5.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

6.  Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.

Authors:  P W Kamphuisen; J C Eikenboom; H L Vos; R Pablo; A Sturk; R M Bertina; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

Review 7.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

8.  A validation study of a retrospective venous thromboembolism risk scoring method.

Authors:  Vinita Bahl; Hsou Mei Hu; Peter K Henke; Thomas W Wakefield; Darrell A Campbell; Joseph A Caprini
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

9.  Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series.

Authors:  Vinayak Anant Padmanabh Hegde; Yoel Vivas; Hiren Shah; David Haybron; Venkatraman Srinivasan; Ashish Dua; Alan Gradman
Journal:  Heart Lung Circ       Date:  2007-07-05       Impact factor: 2.975

10.  Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus.

Authors:  Chi Chiu Mok; Ling Yin Ho; Ka Lung Yu; Chi Hung To
Journal:  Clin Rheumatol       Date:  2010-01-26       Impact factor: 2.980

View more
  2 in total

Review 1.  Optimizing Rheumatoid Arthritis Patients for Surgery.

Authors:  Alana Sigmund; Linda A Russell
Journal:  Curr Rheumatol Rep       Date:  2018-06-25       Impact factor: 4.592

2.  Association of Autoimmune Connective Tissue Disease With Abdominoplasty Outcomes: A Nationwide Analysis of Outcomes.

Authors:  Gustavo A Rubio; Leela S Mundra; Seth R Thaller
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.